Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor We congratulate Wunderink et al1 for their long-term follow up of 7 years of patients with remitted first-episode psychosis. Their results suggest superior rates of social functioning for patients who receive dose reduction/discontinuation compared with maintenance treatment, despite a higher relapse rate during the first 3 years of treatment in the dose reduction/discontinuation group.
Elzinga WS, Schulte PFJ. Dose Reduction/Discontinuation for First-Episode Psychosis. JAMA Psychiatry. 2014;71(5):585. doi:10.1001/jamapsychiatry.2013.4655